Disagree
Home Dragon Pharma Dragon Pharma
Semaglutide
Semaglutide - Dragon Pharma

Semaglutide - Dragon Pharma

Brand:
Category:
Substance:
Package:
5 mg
Price:
$70.00 - $120.00
See options
Product Overview

GLP-1 was found back, in the 80s. Is a hormone made mainly in the intestine and brain that helps regulate blood sugar levels by triggering insulin production and decreasing glucagon levels while also slowing down digestion in the stomach. It all began with studying proglucagon in the 1920s. Now GLP-1 plays a crucial role, in managing type 2 diabetes and obesity by controlling blood sugar levels and appetite which shows promising medical benefits.

References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Semaglutide by Dragon Pharma, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
Where is GLP-1 produced?
It is mainly produced by L-cells in the intestine and neurons in the brainstem.
References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology

How GLP-1 is important for diabetes?
GLP-1 (peptide hormone) improves glucose control, making it effective for treating type 2 diabetes.
References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology

What is the history of GLP-1?
GLP-1 was discovered in the 1980s, building on earlier research about glucagon in the 1960s and 1970s.
References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology